| Name | Title | Contact Details |
|---|
Assertio Therapeutics, Inc. is an American specialty pharmaceutical company.
BioXcel Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on drug development that utilizes novel artificial intelligence to identify the next wave of medicines across neuroscience and immuno-oncology. The company`s drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and proprietary machine learning algorithms to identify new therapeutic indices. The company`s two most advanced clinical development programs are BXCL501, a sublingual thin film formulation designed for acute treatment of agitation resulting from neurological and psychiatric disorders, and BXCL701, an immuno-oncology agent designed for treatment of a rare form of prostate cancer and for treatment of pancreatic cancer.
The Investor Relations website contains information about Cingulate Incs business for stockholders, potential investors, and financial analysts.
Jennerex Biotherapeutics is a San Francisco, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.